Abnormal levels of inflammatory markers such as C-reactive protein and prothrombotic markers like plasminogen activator inhibitor-1 (PAI-1) have been reported in insulin resistant subjects [17] and may contribute to the increased CVD events in this population in combination with dyslipidemia and hypertension [17]. Here, SERPINE1 is linked to metabolic syndrome.